97 results
8-K
EX-99.1
MDXG
Mimedx Group Inc
4 Aug 20
MiMedx Files Second Quarter 2020 Form 10-Q
5:22pm
the effectiveness of the Company’s cost containment actions in offsetting the impact of the COVID-19 pandemic on sales. The business is operating … , excluding the impact of the cash collected on the remaining contracts, resulted primarily from the COVID-19 pandemic causing cancellations
8-K
EX-99.2
MDXG
Mimedx Group Inc
6 Jul 20
MiMedx Announces Filing of 2019 Annual Report
7:00am
pandemic further discussed below. Included in net sales for the quarter ended March 31, 2020 are net sales of $4.5 million related to the contracts … , as the Audit Committee investigation concluded in May 2019.
COVID-19 Impact
Our ability to sell our product has been hampered by the COVID-19 pandemic
8-K
EX-99.1
jqiw4 sd9
21 Apr 20
MiMedx Announces Additional Access to Capital and Financing
2:09pm
8-K
EX-99.1
hsy5g8vh9nuf4trw5ym
11 May 20
MiMedx Provides Update on Payment Protection Program Loan
4:31pm
8-K
EX-99.1
r8ag8y3
16 Apr 20
Regulation FD Disclosure
5:22pm
8-K
EX-99.1
0yc6g95v392p4
28 Feb 22
MIMEDX Announces Fourth Quarter and Full Year 2021
12:00am
8-K
EX-99.1
w0hctptb3
9 Mar 21
MiMedx Announces Fourth Quarter and Full Year 2020 Financial and Operating Results
12:00am
8-K
EX-99.1
brdcc7
10 Mar 21
Regulation FD Disclosure
9:26am
8-K
EX-99.2
dw4bisx5wb c4
10 Jan 22
Results of Operations and Financial Condition
8:05am
DEFA14A
09owp
9 May 22
Additional proxy soliciting materials
8:27am
8-K
EX-99.1
ghkg m64p
8 Jan 21
Regulation FD Disclosure
9:21pm
8-K
vb34dnwrs1
16 Apr 20
Regulation FD Disclosure
5:22pm